Paul J. Converse

3.7k total citations
77 papers, 2.6k citations indexed

About

Paul J. Converse is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Paul J. Converse has authored 77 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 58 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in Paul J. Converse's work include Tuberculosis Research and Epidemiology (54 papers), Mycobacterium research and diagnosis (43 papers) and Infectious Diseases and Tuberculosis (14 papers). Paul J. Converse is often cited by papers focused on Tuberculosis Research and Epidemiology (54 papers), Mycobacterium research and diagnosis (43 papers) and Infectious Diseases and Tuberculosis (14 papers). Paul J. Converse collaborates with scholars based in United States, Netherlands and Ethiopia. Paul J. Converse's co-authors include Eric L. Nuermberger, J Grosset, Deepak V. Almeida, Sandeep Tyagi, Si-Yang Li, William R. Bishai, Rokeya Tasneen, Chiew Ko, Lan H. Ly and Nicole C. Ammerman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Paul J. Converse

77 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Paul J. Converse	1.8k	1.6k	746	482	359	77	2.6k
Selvakumar Subbian	2.1k 1.2×	1.5k 0.9×	993 1.3×	509 1.1×	769 2.1×	116	3.4k
P R Gangadharam	1.3k 0.8×	1.5k 1.0×	556 0.7×	367 0.8×	216 0.6×	104	2.6k
Karen M. Dobos	2.4k 1.4×	2.2k 1.4×	1.7k 2.3×	456 0.9×	1.0k 2.8×	91	4.2k
Lanfranco Fattorini	2.0k 1.2×	1.7k 1.1×	695 0.9×	474 1.0×	668 1.9×	102	3.0k
Hugo L. David	1.7k 1.0×	1.9k 1.2×	765 1.0×	375 0.8×	131 0.4×	106	2.8k
Pilar Domenech	1.7k 1.0×	1.6k 1.0×	623 0.8×	518 1.1×	221 0.6×	31	2.2k
Sang-Nae Cho	2.0k 1.2×	1.8k 1.1×	503 0.7×	762 1.6×	428 1.2×	76	2.6k
Gyanu Lamichhane	2.5k 1.4×	2.1k 1.3×	1.4k 1.9×	457 0.9×	232 0.6×	93	3.9k
Sharon L. Kendall	1.1k 0.6×	903 0.6×	955 1.3×	249 0.5×	181 0.5×	48	2.1k
S W Hunter	1.8k 1.0×	2.0k 1.2×	965 1.3×	417 0.9×	446 1.2×	46	3.3k

Countries citing papers authored by Paul J. Converse

Since Specialization

Citations

This map shows the geographic impact of Paul J. Converse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Converse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Converse more than expected).

Fields of papers citing papers by Paul J. Converse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Converse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Converse. The network helps show where Paul J. Converse may publish in the future.

Co-authorship network of co-authors of Paul J. Converse

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Converse. A scholar is included among the top collaborators of Paul J. Converse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Converse. Paul J. Converse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tyagi, Sandeep, Andrew Garcia, Deepak V. Almeida, et al.. (2024). Contribution of telacebec to novel drug regimens in a murine tuberculosis model. Antimicrobial Agents and Chemotherapy. 69(1). e0096224–e0096224. 1 indexed citations

Xu, Jian, Paul J. Converse, Anna M. Upton, et al.. (2021). Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 65(4). e0141221–e0141221. 39 indexed citations

Almeida, Deepak V., et al.. (2021). Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer. Antimicrobial Agents and Chemotherapy. 65(11). e0141821–e0141821. 10 indexed citations

Almeida, Deepak V., Paul J. Converse, Till F. Omansen, et al.. (2020). Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model. Antimicrobial Agents and Chemotherapy. 64(6). 19 indexed citations

Kubicek-Sutherland, Jessica Z., Dung M. Vu, Aaron S. Anderson, et al.. (2019). Understanding the Significance of Biochemistry in the Storage, Handling, Purification, and Sampling of Amphiphilic Mycolactone. Toxins. 11(4). 202–202. 14 indexed citations

Omansen, Till F., Deepak V. Almeida, Paul J. Converse, et al.. (2018). High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease. Antimicrobial Agents and Chemotherapy. 63(2). 13 indexed citations

Tyagi, Sandeep, Nicole C. Ammerman, Si-Yang Li, et al.. (2015). Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis. Proceedings of the National Academy of Sciences. 112(3). 869–874. 91 indexed citations

Converse, Paul J., Sandeep Tyagi, Yalan Xing, et al.. (2015). Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases. 9(6). e0003823–e0003823. 17 indexed citations

Converse, Paul J., Yalan Xing, Ki Hyun Kim, et al.. (2014). Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases. 8(1). e2618–e2618. 28 indexed citations

10.

Grosset, J, Sandeep Tyagi, Deepak V. Almeida, et al.. (2013). Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice. American Journal of Respiratory and Critical Care Medicine. 188(5). 608–612. 92 indexed citations

11.

Sarfo, Fred Stephen, Paul J. Converse, Deepak V. Almeida, et al.. (2013). Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease. PLoS neglected tropical diseases. 7(3). e2101–e2101. 26 indexed citations

12.

Zhang, Ming, Si-Yang Li, Ian M. Rosenthal, et al.. (2011). Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice. American Journal of Respiratory and Critical Care Medicine. 183(9). 1254–1261. 46 indexed citations

13.

Almeida, Deepak V., Paul J. Converse, Zahoor Ahmad, et al.. (2011). Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice. PLoS neglected tropical diseases. 5(1). e933–e933. 31 indexed citations

14.

Converse, Paul J., Kathleen D. Eisenach, Sue A. Theus, et al.. (2010). The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models. PLoS ONE. 5(4). e10289–e10289. 12 indexed citations

15.

Bryk, Ruslana, Benjamin D. Gold, Aditya Venugopal, et al.. (2008). Selective Killing of Nonreplicating Mycobacteria. Cell Host & Microbe. 3(3). 137–145. 130 indexed citations

16.

Jain, Sanjay K., Qijian Cheng, Prabhpreet Singh, et al.. (2007). Accelerated Detection ofMycobacterium tuberculosisGenes Essential for Bacterial Survival in Guinea Pigs, Compared with Mice. The Journal of Infectious Diseases. 195(11). 1634–1642. 38 indexed citations

17.

Converse, Paul J., Tadesse Wuhib, Mesfin S. Mulatu, & Helmut Kloos. (2003). Bibliography on HIV/AIDS in Ethiopia and Ethiopians in Diaspora. Ethiopian Journal of Health Development. 17(3). 33–85. 2 indexed citations

18.

Converse, Paul J., Tom H. M. Ottenhoff, Gerald E. Hancock, et al.. (1990). Intradermal Recombinant Interleukin 2 Enhances Peripheral Blood T‐Cell Responses to Mitogen and Antigens in Patients with Lepromatous Leprosy. Scandinavian Journal of Immunology. 32(2). 83–91. 17 indexed citations

19.

Kaplan, Gilla, Rolf Kiessling, Gerald E. Hancock, et al.. (1989). The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.. The Journal of Experimental Medicine. 169(3). 893–907. 84 indexed citations

20.

Esa, Ahmed H., Paul J. Converse, & A. D. Hess. (1987). Cyclosporine inhibits soluble antigen and alloantigen presentation by human monocytes in vitro. International Journal of Immunopharmacology. 9(8). 893–902. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact